STOCK TITAN

Vanguard Portfolio Management (CNMD) reports 2.12M shares; 6.87% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

CONMED Corp reported that Vanguard Portfolio Management beneficially owns 2,120,886 shares of Common Stock, representing 6.87% of the class as reported in a Schedule 13G. The filing states Vanguard has sole dispositive power over 2,120,886 shares and sole voting power over 44,469 shares. The filing is signed by Ashley Grim and dated 04/29/2026.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 2,120,886 shares Amount beneficially owned as reported on Schedule 13G
Percent of class 6.87% Percent of common stock ownership as of 03/31/2026
Sole voting power 44,469 shares Shares Vanguard has sole power to vote
Sole dispositive power 2,120,886 shares Shares Vanguard has sole power to dispose or direct disposition
Schedule 13G regulatory
"Schedule 13G filing reporting beneficial ownership"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: 2120886"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power financial
"Sole power to dispose or to direct the disposition of: 2120886"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Investment Company Act of 1940 regulatory
"investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.





207410101

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Portfolio Management LLC and the following affiliates of Vanguard Portfolio Management LLC or business divisions of such affiliates: Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Portfolio Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Portfolio Management LLC, or business divisions of such subsidiaries whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Portfolio Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/29/2026

FAQ

What stake does Vanguard hold in CONMED (CNMD)?

Vanguard Portfolio Management beneficially owns 2,120,886 shares, equal to 6.87% of CONMED's common stock. The Schedule 13G filing shows the position and the percentage of the outstanding class as reported in the filing.

Does Vanguard have voting or disposal control over CNMD shares?

Vanguard reports sole dispositive power over 2,120,886 shares and sole voting power over 44,469 shares. The filing distinguishes dispositive (ability to sell) from voting authority for the reported shares.

When was the Schedule 13G for CNMD signed and filed?

The Schedule 13G excerpt is signed by Ashley Grim with an execution date of 04/29/2026. The ownership snapshot in the filing is tied to a reporting date of 03/31/2026.

Is Vanguard holding these CNMD shares for other clients or funds?

Yes. Vanguard states the reported shares include securities held by Vanguard funds and managed accounts for which Vanguard Portfolio Management LLC or affiliates exercise dispositive power. Specific underlying fund names are not listed in the excerpt.

Does any single other person hold more than 5% of CNMD under Vanguard's filing?

No. The filing states no other person known to Vanguard has an interest exceeding 5% in the reported securities. Vanguard notes holdings include investment companies and managed accounts.